JPS5951263A - 硝酸ピリジルアルキルエステル化合物、その製造法およびそれを含有する医薬製剤 - Google Patents
硝酸ピリジルアルキルエステル化合物、その製造法およびそれを含有する医薬製剤Info
- Publication number
- JPS5951263A JPS5951263A JP58132645A JP13264583A JPS5951263A JP S5951263 A JPS5951263 A JP S5951263A JP 58132645 A JP58132645 A JP 58132645A JP 13264583 A JP13264583 A JP 13264583A JP S5951263 A JPS5951263 A JP S5951263A
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- halogen
- compound according
- hydrogen
- nitrooxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8221592 | 1982-07-26 | ||
| GB8221592 | 1982-07-26 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5951263A true JPS5951263A (ja) | 1984-03-24 |
| JPS6350343B2 JPS6350343B2 (US06291489-20010918-C00045.png) | 1988-10-07 |
Family
ID=10531922
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58132645A Granted JPS5951263A (ja) | 1982-07-26 | 1983-07-19 | 硝酸ピリジルアルキルエステル化合物、その製造法およびそれを含有する医薬製剤 |
Country Status (17)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6081166A (ja) * | 1983-10-11 | 1985-05-09 | Fujisawa Pharmaceut Co Ltd | ２−ニトロオキシメチル−６−クロロピリジンのβ−シクロデキストリン包接化合物およびその製造法 |
| JPS6215A (ja) * | 1985-02-26 | 1987-01-06 | Fujisawa Pharmaceut Co Ltd | ２−ニトロオキシメチル−６−クロロピリジンまたはそのβ−シクロデキストリン包接化合物含有持続性製剤 |
| ZA885069B (en) * | 1987-07-24 | 1989-03-29 | Fujisawa Pharmaceutical Co | Sustained-release percutaneous preparations |
| JPH02167279A (ja) * | 1988-09-30 | 1990-06-27 | Taisho Pharmaceut Co Ltd | アポビンカミン酸誘導体 |
| US5047543A (en) * | 1988-11-24 | 1991-09-10 | Taisho Pharmaceutical Co., Ltd. | 1,4-dihydropyridine derivatives |
| CN106318877A (zh) * | 2016-08-29 | 2017-01-11 | 刘翔 | 一种从茯砖茶中分离、纯化冠突散囊菌及其液态培养方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3275642A (en) * | 1962-04-26 | 1966-09-27 | Bard Pharmaceutical Inc | 3-pyridine carbinol nitrate and its preparation |
| US3689494A (en) * | 1971-03-31 | 1972-09-05 | William R J Simpson | N-pyridinealkyl-alkanolamine nitrates |
-
1983
- 1983-07-05 DK DK311683A patent/DK311683A/da not_active Application Discontinuation
- 1983-07-07 FI FI832490A patent/FI832490L/fi not_active Application Discontinuation
- 1983-07-07 AU AU16635/83A patent/AU565791B2/en not_active Ceased
- 1983-07-11 ZA ZA835048A patent/ZA835048B/xx unknown
- 1983-07-11 GR GR71903A patent/GR78629B/el unknown
- 1983-07-19 JP JP58132645A patent/JPS5951263A/ja active Granted
- 1983-07-20 PH PH29255A patent/PH18083A/en unknown
- 1983-07-20 US US06/515,653 patent/US4540701A/en not_active Expired - Fee Related
- 1983-07-22 ES ES524375A patent/ES524375A0/es active Granted
- 1983-07-23 EP EP83107232A patent/EP0100081B1/en not_active Expired
- 1983-07-23 AT AT83107232T patent/ATE40948T1/de not_active IP Right Cessation
- 1983-07-23 DE DE8383107232T patent/DE3379255D1/de not_active Expired
- 1983-07-25 SU SU833625197A patent/SU1189337A3/ru active
- 1983-07-25 NO NO832700A patent/NO832700L/no unknown
- 1983-07-25 HU HU832615A patent/HU190497B/hu unknown
- 1983-07-26 CA CA000433162A patent/CA1216850A/en not_active Expired
- 1983-07-26 KR KR1019830003459A patent/KR900005470B1/ko active IP Right Grant
-
1985
- 1985-05-08 US US06/731,893 patent/US4613608A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US4540701A (en) | 1985-09-10 |
| DE3379255D1 (en) | 1989-04-06 |
| AU1663583A (en) | 1984-02-02 |
| FI832490L (fi) | 1984-01-27 |
| KR840005426A (ko) | 1984-11-12 |
| US4613608A (en) | 1986-09-23 |
| SU1189337A3 (ru) | 1985-10-30 |
| DK311683D0 (da) | 1983-07-05 |
| GR78629B (US06291489-20010918-C00045.png) | 1984-09-27 |
| ZA835048B (en) | 1984-03-28 |
| HU190497B (en) | 1986-09-29 |
| NO832700L (no) | 1984-02-06 |
| ATE40948T1 (de) | 1989-03-15 |
| FI832490A0 (fi) | 1983-07-07 |
| CA1216850A (en) | 1987-01-20 |
| PH18083A (en) | 1985-03-18 |
| EP0100081A3 (en) | 1985-05-02 |
| ES8502088A1 (es) | 1984-12-16 |
| AU565791B2 (en) | 1987-10-01 |
| JPS6350343B2 (US06291489-20010918-C00045.png) | 1988-10-07 |
| EP0100081B1 (en) | 1989-03-01 |
| EP0100081A2 (en) | 1984-02-08 |
| KR900005470B1 (ko) | 1990-07-30 |
| ES524375A0 (es) | 1984-12-16 |
| DK311683A (da) | 1984-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7105430B1 (ja) | ウイルス増殖阻害作用を有するトリアジン誘導体およびそれらを含有する医薬組成物 | |
| PT2118074E (pt) | Compostos para a prevenção e tratamento de doenças cardiovasculares | |
| EP2632908B1 (en) | Sulfonamides as hiv protease inhibitors | |
| JPH09500908A (ja) | ジヒドロピラゾロピロール類 | |
| JPWO2014133112A1 (ja) | オートタキシン阻害活性を有する８−置換イミダゾピリミジノン誘導体 | |
| PT1352895E (pt) | Derivados de adamantano para o tratamento de doenças inflamatórias, imunitárias e cardiovasculares | |
| JPH11302173A (ja) | ヒストン脱アセチル化酵素阻害剤 | |
| EP1120419B1 (en) | Derivatives of isosorbid mononitrate, utilization as vasodilator agents with reduced tolerance | |
| KR20100044251A (ko) | 특정 화학 물질, 조성물 및 방법 | |
| US20220064105A1 (en) | Crystalline edg-2 receptor antagonist and methods of making | |
| JPS5951263A (ja) | 硝酸ピリジルアルキルエステル化合物、その製造法およびそれを含有する医薬製剤 | |
| WO2018041260A1 (zh) | 一类溴结构域识别蛋白抑制剂及其制备方法和用途 | |
| JP2000053570A (ja) | フェニルイミダゾール系抗高脂血症薬 | |
| KR0181945B1 (ko) | N,n'-비스(알콕시알킬)-피리딘-2,4-디카복실산 디아미드, 이의 제조방법 및 이를 함유하는 약제학적 조성물 | |
| JPS61251683A (ja) | 抗精神病性ベンゾイソチアゾ−ルｓ−オキシド化合物 | |
| US20050154031A1 (en) | 5-Ht2b receptor antagonists | |
| EA018024B1 (ru) | Фенантреноновые соединения, композиции и способы | |
| CN101175758B (zh) | N-[1-(2-乙氧基乙基)-5-(N-乙基-N-甲基氨基)-7-(4-甲基吡啶-2-基-氨基)-1H-吡唑并[4,3-d]嘧啶-3-羰基]甲磺酰胺的无水结晶形式 | |
| JP3484115B2 (ja) | 縮合ピリダジン誘導体、その製造法および用途 | |
| WO2000068231A1 (fr) | Dihydrate derive de purine, medicaments le contenant comme principe actif et intermediaire utilise dans sa preparation | |
| CA3188308A1 (en) | Substituted n-phenylacetamides having p2x4 receptor antagonistic activity | |
| KR100361834B1 (ko) | 폴리에톡실레이티드 피라졸로피리미디논 유도체, 그의제조방법 및 그를 포함하는 발기부전증 치료용 약제학적조성물 | |
| CN116768815A (zh) | 靛红酸酐类化合物及其制备方法和用途 | |
| CN116529234A (zh) | 结晶edg-2受体拮抗剂及制备方法 | |
| JPS6215547B2 (US06291489-20010918-C00045.png) |
